Ethical Compliance

HIKAL
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
0.1%
Debt
32.8%
Liquidity
0.8%
Revenue
Debt
Liquidity
0.1%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
Crop Protection | ₹684.43 |
Pharmaceuticals | ₹1,100.17 |
Other Income | ₹0.39 |
Questionable
INR Crores
Dividend income | ₹0.00 |
Non Compliant
INR Crores
Interest income | ₹2.07 |
INR Crores
Revenue from Questionable Sources: | ₹0.00 |
Revenue from Non Compliant Sources: | ₹2.07 |
Total: | ₹2.07 |
Total Revenue: | ₹1,787.05 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹2.07
₹1,787.05
= 0.1%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.